scispace - formally typeset
Journal ArticleDOI

Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection.

Reads0
Chats0
TLDR
There will be relatively long-lived protection from re-infection following symptomatic COVID-19 disease, and there was a high level of correlation between PRNT50 antibody titers and the % of inhibition in surrogate virus neutralization tests.
About
This article is published in EClinicalMedicine.The article was published on 2021-10-30. It has received 48 citations till now. The article focuses on the topics: Antibody titer & Neutralizing antibody.

read more

Citations
More filters
Journal ArticleDOI

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

TL;DR: In this paper , the authors showed that a 50% plaque reduction neutralization antibody titer (PRNT50) ≥ 25.6 in their live virus assay corresponded to the threshold for 50% protection from infection against wild-type (WT) SARS-CoV-2 Omicron variant.
Journal ArticleDOI

SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity

TL;DR: In this paper , a narrative review provides an overview on epidemiological studies addressing the issue of SARS-CoV-2 infection and the efficacy and duration of natural immunity in terms of protection against reinfections and severe disease.
Journal ArticleDOI

Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events

TL;DR: This study has identified specific gut microbiota markers in association with improved immune response and reduced adverse events following COVID-19 vaccines, indicating that microbiota-targeted interventions have the potential to complement effectiveness of CO VID-19 vaccine.
Journal ArticleDOI

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents

TL;DR: In this article , an interim analysis of a registered clinical study (NCT04800133) to establish immunobridging with various antibody and cellular immunity markers and to compare the immunogenicity and reactogenicity of 2-dose BNT162b2 and CoronaVac in healthy adolescents as primary objectives.
References
More filters
Journal ArticleDOI

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.

TL;DR: It is shown that neutralization level is highly predictive of immune protection, and an evidence-based model of SARS-CoV-2 immune protection that will assist in developing vaccine strategies to control the future trajectory of the pandemic is provided.
Journal ArticleDOI

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.

TL;DR: Infection with betacoronaviruses induces multi-specific and long-lasting T cell immunity against the structural N protein, and SARS-CoV-2-reactive T cells were found in individuals who had recovered from SARS or COVID-19 and in unexposed donors, although with different patterns of immunoreactivity.
Related Papers (5)